查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1972093

心臟辅助设备市场：2026-2032年全球预测（按产品类型、适应症、供应模式、最终用户、应用和通路）

Cardiac Assist Devices & Equipment Market by Product Type, Indication, Delivery Mode, End User, Application, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，心臟辅助设备市场价值将达到 19.4 亿美元，到 2026 年将成长至 20.8 亿美元，到 2032 年将达到 33.2 亿美元，复合年增长率为 7.96%。

主要市场统计数据
基准年 2025 19.4亿美元
预计年份：2026年 20.8亿美元
预测年份 2032 33.2亿美元
复合年增长率 (%) 7.96%

在急性和慢性心血管护理路径中，将心臟辅助装置的战略重要性置于临床发展和运作压力的背景下进行定位。

引言部分阐述了心臟支持装置及相关设备在现代心血管治疗中的应用范围和关键意义。过去十年间，技术进步、临床路径的变革以及患者人群结构的变化，使得心室支持装置、主动脉内球囊反搏泵、导管式心室支持装置和体外膜肺氧合（ECMO）等装置成为生命维持的核心。临床医生和医疗系统领导者如今不仅将这些技术视为救命措施，更将其视为贯穿急性期稳定、过渡策略和长期循环支持的综合治疗路径的重要组成部分。

设备设计、微创输送方法、数位遥测和混合护理路径的创新如何重塑临床医生的实践和供应商的差异化。

心臟辅助装置领域正经历一场变革，其驱动力来自于装置设计、手术方法和临床证据的创新。连续流心室辅助装置正从小众的救命工具发展成更持久的临终治疗方案。同时，基于导管的心室辅助系统在缩短手术时间和扩大高风险经皮治疗的应用范围方面取得了显着进展。这些技术进步与体外膜氧合（ECMO）技术的进步相辅相成，ECMO强调便携性、氧合效率和简化的抗凝血策略，从而加速了其适应症的扩展和临床应用。

因应不断变化的关税政策所带来的连锁反应：加强供应链韧性、在地化和降低采购风险的策略。

到2025年，关税政策调整和贸易措施的累积影响，给依赖跨境供应链生产心臟辅助设备和耗材的製造商、经销商和医疗保健系统带来了新的挑战。关税相关的成本压力进一步凸显了本地生产、区域供应合约和库存优化策略的重要性，这些策略有助于降低到岸成本和采购前置作业时间波动的影响。在此背景下，采购团队被迫重新评估供应商选择，并专注于供应的连续性和合约保障，以应对关税波动和海关相关的延误。

产品架构、临床应用、医疗保健环境、治疗方法和通路方面的细微细分如何影响差异化的商业和临床策略？

细分市场分析揭示了产品类型、医疗环境、临床应用、适应症、给药方式和分销管道如何独特地影响整个价值链中的技术采纳和服务需求。在产品类型中，存在着种类繁多的设备，从在高风险介入治疗期间提供短期循环支持的导管式心室辅助系统，到作为重症监护支持平台的体外膜肺氧合（ECMO）系统。主动脉内球囊反搏帮浦仍是血流动力学稳定的战术性支援工具。同时，心室辅助装置分为连续流和脉动流两种类型，可处理各种慢性及急性循环衰竭病例。连续流平台进一步细分为左心室辅助装置、右心室辅助装置和双心室辅助装置，每种装置都有其独特的植入复杂性、追踪需求和临床结果特征。

管理体制、临床能力和报销优先事项方面的区域差异决定了全球市场的引进管道和商业化策略。

区域趋势对医疗器材的设计重点、监理合规路径和商业推广策略有显着影响。在美洲，重点在于与三级医疗网络合作、建立健全的先进疗法报销机制，以及需要以疗效主导的证据来支持医疗器材的长期应用。在该地区，领先的医疗中心和高运转率的三级医院在製定临床通讯协定和建立培训模式方面发挥核心作用，这种影响力会向下辐射到规模较小的医院和专科心臟中心。

竞争优势由模组化技术平台、整合服务模式和临床伙伴关係关係所构成。

心臟辅助设备领域的竞争格局由技术差异化、全生命週期服务以及与临床机构的策略合作共同塑造。领先的製造商正投资于模组化平台，以方便升级并与监测生态系统互通性；而新参与企业则专注于小众价值提案，例如设备便携性、简化的抗凝血方案，或将技术与培训和远端支援相结合的服务型经营模式。

为製造商和医疗保健系统提供切实可行的策略，以加速医疗设备的采用，增强供应链的韧性，并在护理路径中实现基于价值的临床整合。

产业领导者应优先应对三大策略挑战，以在不断发展的心臟辅助设备市场中创造价值并降低风险。首先，投资于设备相容性和模组化架构，以实现功能升级并与监测生态系统整合。这种方法可以降低买方的生命週期成本，并支援差异化的升级路径。其次，透过组件来源多元化、评估区域组装或最终阶段整合以及谈判贸易附加条款来增强供应链韧性，从而抵御关税波动和物流中断的影响。

我们进行稳健的混合方法研究，结合临床医生的见解、监管和技术审查以及供应链情境分析，得出可操作且检验的结论。

本调查方法采用混合方法，整合了定性专家访谈、器械技术评估、监管环境审查和供应链分析，以全面了解心臟辅助器械产业。研究透过对循环系统医生、介入性心臟病专家、循环管理技师、采购经理和医院高级管理人员进行结构化访谈，获取关键讯息，以了解实际运作情况和推广应用障碍。此外，研究还利用监管申报文件、已发表的临床文献和器械技术规范进行二次分析，以检验性能特征并明确区分不同器械类别。

临床创新、供应韧性和有针对性的商业化正在融合，形成关键趋势的汇聚，从而实现先进心臟辅助技术的永续整合。

总之，心臟辅助设备及相关设备的市场格局呈现出创新加速、临床模式转变以及供应链和政策日益复杂的特征。设备设计的不断改进、微创植入方法的进步以及远端监测技术的进步，为更广泛的应用铺平了道路；而关税趋势和区域监管差异则要求企业製定适应性强的商业和营运策略。设备类型、医疗环境、临床应用和分销管道之间的相互作用，需要进行精准的市场细分，以指导产品开发和市场进入策略的发展。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 心臟辅助装置与设备市场：依产品类型划分

  • 导管式心室辅助系统
  • 体外膜氧合器
  • 主动脉内球囊反搏泵
  • 心室辅助装置
    • 连续流
      • 双心室辅助装置
      • 左心室辅助装置
      • 右心辅助装置
    • 脉动流速

第九章：心臟辅助装置与设备市场：依适应症划分

  • 双心室衰竭
  • 左心臟衰竭
  • 右心臟衰竭

第十章：心臟辅助装置及设备市场：依交付方式划分

  • 侵入性
  • 微创

第十一章 心臟辅助设备市场：依最终使用者划分

  • 门诊手术中心
  • 心臟中心
  • 医院

第十二章 心臟辅助装置及设备市场：依应用领域划分

  • 弥合復苏差距
  • 弥合移植差距
  • 最终治疗

第十三章 心臟辅助设备市场：依通路划分

  • 直销
  • 批发的

第十四章 心臟辅助设备市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 心臟辅助装置及设备市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 心臟辅助设备市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章：美国心臟辅助装置及设备市场

第十八章：中国心臟辅助设备市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • Abiomed, Inc.
  • Baxter International Inc.
  • Berlin Heart GmbH
  • BiVACOR Inc
  • Getinge AB
  • Jarvik Heart, Inc
  • LivaNova PLC
  • Medos Medizintechnik AG
  • Medtronic plc
  • Teleflex Incorporated
  • Terumo Corporation
Product Code: MRR-2B5802CFEB47

The Cardiac Assist Devices & Equipment Market was valued at USD 1.94 billion in 2025 and is projected to grow to USD 2.08 billion in 2026, with a CAGR of 7.96%, reaching USD 3.32 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.94 billion
Estimated Year [2026] USD 2.08 billion
Forecast Year [2032] USD 3.32 billion
CAGR (%) 7.96%

Framing the strategic significance of cardiac assist devices amid clinical evolution and operational pressures across acute and chronic cardiovascular care pathways

The opening synopsis establishes the scope and critical importance of cardiac assist devices and allied equipment in modern cardiovascular care. Over the past decade, technological advances, changing clinical pathways, and evolving patient demographics have placed devices such as ventricular assist systems, intra-aortic balloon pumps, catheter-based ventricular support systems, and extracorporeal membrane oxygenation at the center of life-sustaining therapies. Clinicians and health system leaders now regard these technologies not merely as rescue interventions but as integrated components of care pathways that span acute stabilization, bridge strategies, and long-term circulatory support.

Consequently, stakeholders ranging from hospital procurement teams to specialized cardiac centers are wrestling with decisions that require balancing clinical efficacy, procedural complexity, reimbursement considerations, and capital planning. As the ecosystem matures, collaboration between device manufacturers, service providers, clinicians, and payers becomes increasingly vital. The introductory framing emphasizes how device modularity, procedural innovation, and patient-centered design are reshaping both inpatient workflows and post-procedure management, thereby redefining expectations for device performance and vendor partnerships.

Ultimately, the introduction positions the reader to appreciate subsequent sections that examine transformative shifts, policy impacts, segmentation dynamics, and regional nuances that collectively inform strategic decision making across the cardiac assist device landscape.

How innovation in device design, minimally invasive delivery, digital telemetry, and hybrid care pathways is reshaping clinician practice and vendor differentiation

The landscape for cardiac assist devices is undergoing transformative shifts driven by innovation in device architecture, procedural approaches, and clinical evidence generation. Continuous-flow ventricular assist devices have moved from niche rescue tools to increasingly durable options for destination therapy, while catheter-based ventricular support systems are enabling shorter procedural times and broader applicability in high-risk percutaneous interventions. These technological trajectories are complemented by advances in extracorporeal membrane oxygenation that emphasize portability, oxygenator efficiency, and simplified anticoagulation strategies, thereby expanding indications and point-of-care deployment.

Meanwhile, the rhythm of adoption is influenced by improvements in minimally invasive delivery modes and hybrid procedural models that combine percutaneous and surgical techniques. As a result, delivery models and clinical teams must adapt, incorporating cross-disciplinary training and reconfigured care pathways to support post-procedural monitoring, infection control, and remote patient management. In parallel, manufacturers are increasingly integrating digital telemetry and remote monitoring capabilities to support earlier discharge and longitudinal follow-up, which in turn pressures service models and reimbursement frameworks to evolve.

Consequently, these converging trends create opportunities for market entrants and incumbents to differentiate through device interoperability, lifecycle services, and evidence generation that demonstrates real-world outcomes. In short, the field is moving toward a more connected, patient-centric paradigm that emphasizes procedural efficiency, long-term management, and value-based performance.

Navigating the downstream effects of evolving tariff policies through supply chain resilience, localization, and procurement risk mitigation strategies

The cumulative effects of tariff policy shifts and trade measures enacted through 2025 have introduced new considerations for manufacturers, distributors, and health systems that rely on cross-border supply chains for cardiac assist devices and consumables. Tariff-related cost pressures have accentuated the importance of localized manufacturing, regional supply agreements, and inventory optimization strategies to mitigate variability in landed cost and procurement lead times. In this environment, procurement teams have had to reassess vendor sourcing, with an emphasis on supply continuity and contractual protections that address tariff volatility and customs-related delays.

Moreover, regulatory harmonization and documentation requirements tied to customs classifications have required closer coordination between regulatory affairs and commercial functions, as compliance missteps can compound tariff-related financial exposure. Consequently, some manufacturers have accelerated plans for regional assembly or selected component localization to preserve competitiveness while maintaining clinical performance standards. Other organizations have prioritized strategic stockpiling of critical components and sought long-term agreements with logistics partners capable of managing customs complexities and expedited cross-border movements.

In addition, the tariff landscape has implications for the rollout cadence of next-generation devices. Developers must factor in not only development timelines and clinical validation but also the economics of distribution under shifting trade regimes. Collectively, these responses underscore a broader shift toward resilient supply chain architectures that place equal weight on trade risk mitigation, regulatory conformity, and sustaining clinical access across diverse care settings.

How nuanced segmentation across product architectures, clinical applications, care settings, procedural approaches, and distribution routes informs differentiated commercial and clinical strategies

Segmentation analysis illuminates how product typologies, care settings, clinical applications, indications, delivery modes, and distribution channels uniquely shape technology adoption and service requirements across the value chain. Within product categories, devices range from catheter-based ventricular support systems that support short-term circulatory assistance during high-risk interventions to extracorporeal membrane oxygenation systems that serve as intensive support platforms. Intra-aortic balloon pumps remain a tactical adjunct for hemodynamic stabilization, while ventricular assist devices, split between continuous flow and pulsatile flow architectures, address a spectrum of chronic and acute circulatory failures. Continuous-flow platforms further fragment into devices intended for left, right, and biventricular support, each presenting distinct implantation complexity, follow-up needs, and clinical outcome profiles.

End-user segmentation highlights divergent procurement and operational priorities across ambulatory surgical centers, dedicated cardiac centers, and general hospitals. Ambulatory surgical centers emphasize throughput, minimally invasive delivery, and low-footprint solutions, whereas cardiac centers prioritize advanced device capabilities, specialized staff competencies, and research collaborations. Hospitals balance acute care readiness with capital planning and intensive care capacity.

Regarding application, therapies are deployed across bridge-to-recovery, bridge-to-transplant, and destination therapy contexts, and each application imposes different clinical monitoring, device durability, and patient selection considerations. Indication-based differentiation across biventricular failure, left heart failure, and right heart failure further complicates device selection and care pathways, since physiologic support requirements and complication profiles vary substantially. Delivery mode categorization into invasive and minimally invasive approaches shifts not only procedural staffing and training needs but also impacts perioperative pathway design. Lastly, distribution channels-direct sales versus distributor models-affect contractual relationships, service-level agreements, and the feasibility of integrated post-market services such as training, maintenance, and remote monitoring deployment.

Regional variations in regulatory regimes, clinical capacity, and reimbursement priorities that determine adoption pathways and commercialization tactics across global markets

Regional dynamics exert a strong influence on device design priorities, regulatory pathways, and commercial deployment strategies. Across the Americas, the emphasis rests on integration with tertiary care networks, robust reimbursement frameworks for advanced therapies, and an appetite for outcomes-driven evidence that supports long-term device adoption. In this region, centers of excellence and high-volume tertiary hospitals play a central role in establishing clinical protocols and training models that ripple outward to smaller hospitals and specialized cardiac centers.

In Europe, the Middle East & Africa, the regulatory environment and heterogeneous payer systems shape adoption timelines and the types of devices prioritized, with an emphasis on interoperability, compliance with regional device directives, and flexible service models that can accommodate diverse health system capacities. In addition, pockets of advanced cardiac care coexist with underserved regions, prompting manufacturers to tailor device portfolios across cost, complexity, and support offerings. Partnerships with regional distributors and clinical training organizations are therefore critical to scale adoption.

Asia-Pacific presents a varied landscape characterized by rapid infrastructure investment, growing clinical capacity for advanced cardiac interventions, and a rising focus on minimally invasive and portable solutions that serve both urban centers and expanding regional hospitals. Furthermore, local manufacturing initiatives and policies supporting domestic medical technology industries influence strategic choices for multinational suppliers, while demographic trends drive demand for chronic circulatory support and post-acute care innovations.

Competitive dynamics defined by modular technological platforms, integrated service models, and clinical partnerships that accelerate adoption and long-term device utilization

Competitive dynamics in the cardiac assist device domain are shaped by a combination of technological differentiation, lifecycle service offerings, and strategic partnerships with clinical institutions. Leading manufacturers are investing in modular platforms that facilitate upgrades and interoperability with monitoring ecosystems, while new entrants focus on niche value propositions such as device portability, simplified anticoagulation profiles, or service-centric business models that bundle technology with training and remote support.

Collaborations between device makers and digital health providers are accelerating the integration of telemetry and predictive analytics, which enhances post-implant surveillance and supports remote care pathways. Simultaneously, contract and service models are evolving to include outcomes-based components and extended maintenance agreements, reflecting buyer preferences for predictable total cost of ownership and clinical performance guarantees.

From a commercialization perspective, companies that can align clinical evidence generation with targeted reimbursement strategies and scalable training programs are positioned to capture sustainable adoption across complex hospital networks and specialized cardiac centers. Strategic M&A, licensing arrangements for components or software, and partnerships with regional distributors remain prominent routes to expand footprint while managing regulatory and logistical complexities.

Actionable strategies for manufacturers and health systems to drive device adoption, supply resilience, and value-based clinical integration across care pathways

Industry leaders should prioritize a three-fold strategic agenda to capture value and mitigate risk in an evolving cardiac assist devices environment. First, invest in device compatibility and modular architectures that allow feature upgrades and integration with monitoring ecosystems; this approach reduces lifecycle costs for buyers and supports differentiated upgrade pathways. Second, strengthen supply chain resilience by diversifying component sourcing, evaluating regional assembly or final-stage integration, and negotiating trade-contingent contractual terms that protect against tariff volatility and logistical disruptions.

Third, align commercial and clinical strategies by investing in evidence generation that speaks to real-world outcomes across bridge-to-recovery, bridge-to-transplant, and destination therapy cohorts; simultaneously, develop service offerings that include structured training, remote monitoring, and maintenance agreements to reduce clinician burden and improve device uptime. In parallel, adopt flexible distribution strategies that balance direct sales where clinical complexity demands close vendor involvement with selective distributor partnerships for broader reach in fragmented markets.

Finally, cultivate partnerships with health systems and payers to pilot value-based contracting models and supply utilization programs. By doing so, leaders can demonstrate economic case studies that complement clinical evidence and expedite the integration of advanced support devices into standard care pathways.

Robust mixed-methods research combining clinician insights, regulatory and technical reviews, and supply chain scenario analysis to derive actionable and validated conclusions

The research methodology combines a mixed-methods approach that integrates qualitative expert interviews, device technology assessments, regulatory landscape reviews, and supply chain analysis to form a holistic view of the cardiac assist device space. Primary inputs include structured interviews with cardiovascular surgeons, interventional cardiologists, perfusionists, procurement leaders, and senior hospital administrators to capture operational realities and adoption barriers. Secondary analysis draws on regulatory filings, published clinical literature, and device technical specifications to validate performance characteristics and differentiate device classes.

To ensure rigor, findings are triangulated across multiple data streams and cross-checked with clinician feedback on real-world usability, training needs, and complication management. Supply chain assessment employs scenario analysis to evaluate the implications of trade policy shifts, logistics constraints, and component concentration risks. Competitive mapping synthesizes public company disclosures, product portfolios, and partnership announcements to depict strategic positioning without relying on proprietary or restricted data.

Throughout the methodology, care is taken to preserve confidentiality of interviewees and to present aggregated insights that reflect sector-wide trends rather than identifiable commercial metrics. This approach ensures that recommendations are actionable, clinically grounded, and sensitive to the operational constraints faced by health systems and device suppliers.

Synthesis of key trends showing how clinical innovation, supply resilience, and targeted commercialization together enable sustainable integration of advanced cardiac support technologies

In conclusion, the cardiac assist devices and equipment landscape is characterized by accelerating innovation, shifting clinical paradigms, and heightened supply chain and policy complexity. Continuous improvements in device design, minimally invasive delivery, and remote monitoring create pathways for broader adoption, while tariff dynamics and regional regulatory variability necessitate adaptive commercial and operational strategies. The interplay of device typology, care setting, clinical application, and distribution approach requires nuanced segmentation to inform product development and go-to-market decisions.

Collectively, manufacturers and health systems that embrace modular design, prioritize evidence aligned with specific indications and applications, and invest in resilient supply and service models will be better positioned to meet clinician expectations and patient needs. As the ecosystem continues to evolve, collaboration across clinical, commercial, and regulatory functions will be essential to translate technological advances into improved outcomes and sustainable care models. In short, the field is ripe for strategic action that harmonizes clinical efficacy with pragmatic operational planning.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Cardiac Assist Devices & Equipment Market, by Product Type

  • 8.1. Catheter-Based Ventricular Support System
  • 8.2. Extracorporeal Membrane Oxygenation
  • 8.3. Intra-Aortic Balloon Pump
  • 8.4. Ventricular Assist Device
    • 8.4.1. Continuous Flow
      • 8.4.1.1. Biventricular Assist Device
      • 8.4.1.2. Left Ventricular Assist Device
      • 8.4.1.3. Right Ventricular Assist Device
    • 8.4.2. Pulsatile Flow

9. Cardiac Assist Devices & Equipment Market, by Indication

  • 9.1. Biventricular Failure
  • 9.2. Left Heart Failure
  • 9.3. Right Heart Failure

10. Cardiac Assist Devices & Equipment Market, by Delivery Mode

  • 10.1. Invasive
  • 10.2. Minimally Invasive

11. Cardiac Assist Devices & Equipment Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Cardiac Centers
  • 11.3. Hospitals

12. Cardiac Assist Devices & Equipment Market, by Application

  • 12.1. Bridge To Recovery
  • 12.2. Bridge To Transplant
  • 12.3. Destination Therapy

13. Cardiac Assist Devices & Equipment Market, by Distribution Channel

  • 13.1. Direct Sales
  • 13.2. Distributor Sales

14. Cardiac Assist Devices & Equipment Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Cardiac Assist Devices & Equipment Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Cardiac Assist Devices & Equipment Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Cardiac Assist Devices & Equipment Market

18. China Cardiac Assist Devices & Equipment Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Abbott Laboratories
  • 19.6. Abiomed, Inc.
  • 19.7. Baxter International Inc.
  • 19.8. Berlin Heart GmbH
  • 19.9. BiVACOR Inc
  • 19.10. Getinge AB
  • 19.11. Jarvik Heart, Inc
  • 19.12. LivaNova PLC
  • 19.13. Medos Medizintechnik AG
  • 19.14. Medtronic plc
  • 19.15. Teleflex Incorporated
  • 19.16. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DELIVERY MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY CATHETER-BASED VENTRICULAR SUPPORT SYSTEM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY CATHETER-BASED VENTRICULAR SUPPORT SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY CATHETER-BASED VENTRICULAR SUPPORT SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY INTRA-AORTIC BALLOON PUMP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY INTRA-AORTIC BALLOON PUMP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY INTRA-AORTIC BALLOON PUMP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY CONTINUOUS FLOW, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY CONTINUOUS FLOW, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY CONTINUOUS FLOW, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY BIVENTRICULAR ASSIST DEVICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY BIVENTRICULAR ASSIST DEVICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY BIVENTRICULAR ASSIST DEVICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY RIGHT VENTRICULAR ASSIST DEVICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY RIGHT VENTRICULAR ASSIST DEVICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY RIGHT VENTRICULAR ASSIST DEVICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY PULSATILE FLOW, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY PULSATILE FLOW, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY PULSATILE FLOW, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY BIVENTRICULAR FAILURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY BIVENTRICULAR FAILURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY BIVENTRICULAR FAILURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY LEFT HEART FAILURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY LEFT HEART FAILURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY LEFT HEART FAILURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY RIGHT HEART FAILURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY RIGHT HEART FAILURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY RIGHT HEART FAILURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY INVASIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY INVASIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY INVASIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY CARDIAC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY CARDIAC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY BRIDGE TO RECOVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY BRIDGE TO RECOVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY BRIDGE TO RECOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DESTINATION THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DESTINATION THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DESTINATION THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DISTRIBUTOR SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DISTRIBUTOR SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. MIDDLE EAST CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 127. MIDDLE EAST CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 128. MIDDLE EAST CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. MIDDLE EAST CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. MIDDLE EAST CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 135. AFRICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 136. AFRICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. AFRICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. AFRICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 150. ASEAN CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. ASEAN CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. ASEAN CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 153. ASEAN CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 154. ASEAN CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 155. ASEAN CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 156. ASEAN CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. ASEAN CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. ASEAN CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 159. GCC CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. GCC CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. GCC CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 162. GCC CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 163. GCC CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 164. GCC CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 165. GCC CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. GCC CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. GCC CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPEAN UNION CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPEAN UNION CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPEAN UNION CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPEAN UNION CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPEAN UNION CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPEAN UNION CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPEAN UNION CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPEAN UNION CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPEAN UNION CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 177. BRICS CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. BRICS CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. BRICS CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 180. BRICS CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 181. BRICS CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 182. BRICS CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 183. BRICS CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 184. BRICS CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. BRICS CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 186. G7 CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. G7 CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. G7 CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 189. G7 CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 190. G7 CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 191. G7 CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 192. G7 CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 193. G7 CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 194. G7 CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 195. NATO CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. NATO CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. NATO CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 198. NATO CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 199. NATO CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 200. NATO CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 201. NATO CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. NATO CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 203. NATO CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 204. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. UNITED STATES CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 206. UNITED STATES CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. UNITED STATES CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 208. UNITED STATES CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 209. UNITED STATES CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 210. UNITED STATES CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 211. UNITED STATES CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 212. UNITED STATES CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 213. UNITED STATES CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 214. CHINA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 215. CHINA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. CHINA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 217. CHINA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 218. CHINA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 219. CHINA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 220. CHINA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 221. CHINA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 222. CHINA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)